Contract Funding Opportunities Available for Innovative SBIR Development | Office of Cancer Clinical Proteomics Research

Contract Funding Opportunities Available for Innovative SBIR Development

Does your small business need early-stage financing to take its cancer research to the next level? The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center has released $5 million for new contract funding opportunities to support cancer research and technology development in key emerging areas of need. The NCI SBIR can help you finance and advance innovations in cancer prevention, diagnosis, treatment, and basic research. Applications are due by 4:30 p.m. ET on November 13, 2013. The NCI solicits proposals for SBIR contracts only once annually, so don't miss your chance!

The FY2014 NIH/CDC SBIR contract solicitation provides funding opportunities to small businesses to support the research, development, and ultimately commercialization in the following areas including:

Advancing Cancer Research

  • 328 Validation of 3D Human Tissue Culture Systems that Mimic the Tumor Microenvironment
  • 329 Proteomic Analysis of Single Cells Isolated from Solid Tumors
  • 330 Generation of Site-Specific Phospho-Threonine Protein Standards for use in Cancer Assays

If you have questions about any of the topics or general questions on contract administration, please contact:
Ms. Elizabeth Shanahan eshanahan@mail.nih.gov Phone: (240) 276-5432